Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Humana
HUM
|
$1.61B |
| 2 |
CVS Health
CVS
|
$1.22B |
| 3 |
Norfolk Southern
NSC
|
$573M |
| 4 |
Johnson Controls International
JCI
|
$355M |
| 5 |
Coupang
CPNG
|
$254M |
Top Sells
| 1 |
Cigna
CI
|
$1.41B |
| 2 |
Wells Fargo
WFC
|
$1.36B |
| 3 |
Hewlett Packard
HPE
|
$1.01B |
| 4 |
Microchip Technology
MCHP
|
$738M |
| 5 |
Capital One
COF
|
$615M |
Sector Composition
| 1 | Healthcare | 21.14% |
| 2 | Financials | 20.84% |
| 3 | Technology | 12.56% |
| 4 | Communication Services | 12.34% |
| 5 | Industrials | 11.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
JPMorgan Chase
JPM
$829B
| $62.3M | 0.04% | 307,915 -12,650 | -4% | -$2.56M |
|
|
102
Microchip Technology
MCHP
$35.1B
| $56.9M | 0.03% | 621,961 -8,066,067 | -93% | -$738M |
|
103
Eli Lilly
LLY
$657B
| $41.6M | 0.03% | 45,978 -947 | -2% | -$857K |
|
104
Schlumberger
SLB
$55B
| $31.6M | 0.02% | 670,479 -62,368 | -9% | -$2.94M |
|
105
GE Vernova
GEV
$167B
| $31.4M | 0.02% | +182,865 | New | +$31.4M |
|
106
Walt Disney
DIS
$213B
| $30.4M | 0.02% | 305,856 -5,022 | -2% | -$499K |
|
107
Chevron
CVX
$324B
| $28.9M | 0.02% | 184,453 -885 | -0.5% | -$138K |
|
108
Travelers Companies
TRV
$61.1B
| $23M | 0.01% | 112,870 | – | – |
|
109
Merck
MRK
$210B
| $19.7M | 0.01% | 158,876 -1,619 | -1% | -$200K |
|
110
Target
TGT
$43.6B
| $17.2M | 0.01% | 116,294 -1,505 | -1% | -$223K |
|
|
111
Hewlett Packard
HPE
$29.6B
| $15.8M | 0.01% | 747,383 -47,746,489 | -98% | -$1.01B |
|
112
Procter & Gamble
PG
$368B
| $15.7M | 0.01% | 94,903 -900 | -0.9% | -$148K |
|
113
TSMC
TSM
$1.2T
| $15M | 0.01% | 86,500 | – | – |
|
114
Thermo Fisher Scientific
TMO
$186B
| $14.8M | 0.01% | 26,791 -7 | -0% | -$3.87K |
|
115
Caterpillar
CAT
$196B
| $14.1M | 0.01% | 42,276 -50 | -0.1% | -$16.7K |
|
116
Walmart
WMT
$774B
| $13.7M | 0.01% | 201,810 -5,050 | -2% | -$342K |
|
117
Adobe
ADBE
$151B
| $12M | 0.01% | 21,602 -78 | -0.4% | -$43.3K |
|
118
AstraZeneca
AZN
$248B
| $11.7M | 0.01% | 149,785 -5,500 | -4% | -$429K |
|
119
Exxon Mobil
XOM
$487B
| $9.19M | 0.01% | 79,812 -547 | -0.7% | -$63K |
|
120
Home Depot
HD
$405B
| $8.43M | 0.01% | 24,482 -335 | -1% | -$115K |
|
121
Boston Scientific
BSX
$156B
| $7.48M | ﹤0.01% | 97,095 | – | – |
|
122
Analog Devices
ADI
$124B
| $7.26M | ﹤0.01% | 31,815 -100 | -0.3% | -$22.8K |
|
|
HES
123
DELISTED
Hess
HES
| $6.87M | ﹤0.01% | 46,550 -1,050 | -2% | -$155K |
|
124
Synopsys
SNPS
$112B
| $6.81M | ﹤0.01% | 11,450 | – | – |
|
125
Vulcan Materials
VMC
$38.5B
| $6.14M | ﹤0.01% | 24,700 | – | – |
|